Education
About Us
Working with TipRanks
Follow Us
Liquidmetal Technologies Inc (LQMT)
OTHER OTC:LQMT
Top Page
Liquidmetal Technologies
(OTC:LQMT)
Select Model
Select Model
Rating:47Neutral
Price Target:
$0.11
▲(8.00% Upside)
Action:ReiteratedDate:01/18/26
The score is held down primarily by very weak financial performance: shrinking small revenue, extreme net losses, and ongoing negative operating/free cash flow. Technical indicators provide some offset with moderately positive momentum, but valuation is constrained by negative earnings and no dividend support.
Positive Factors
Revenue Growth
Strong revenue growth indicates successful market penetration and product adoption, enhancing the company's market position and potential for future profitability.
FDA Approval
FDA approval opens up significant business opportunities in health monitoring solutions, potentially driving long-term revenue and market expansion.
Strong Balance Sheet
A strong balance sheet with low leverage provides financial stability and flexibility, supporting sustainable growth and resilience against economic fluctuations.
Negative Factors
Profitability Challenges
Ongoing profitability issues highlight operational inefficiencies and cost management challenges, potentially hindering long-term financial health and shareholder returns.
Cash Flow Strain
Negative cash flows indicate liquidity challenges, limiting the company's ability to invest in growth opportunities and manage financial obligations effectively.
Tariff Impact
Tariff-related cost increases could erode competitive pricing and margins, affecting the company's ability to maintain market share and profitability.
Liquidmetal Technologies (LQMT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$116.66M
Dividend YieldN/A
Average Volume (3M)463.77K
Price to Earnings (P/E)―
Beta (1Y)0.88
Revenue Growth-27.53%
EPS Growth-64.29%
CountryUS
Employees7
SectorIndustrials
Sector Strength72
IndustryManufacturing - Metal Fabrication
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding917,285,160
10 Day Avg. Volume526,030
30 Day Avg. Volume463,771
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)1.33
Price to Sales (P/S)45.33
P/FCF Ratio-33.69
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue154.10
Enterprise Value/Gross Profit513.88
Enterprise Value/Ebitda-43.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Liquidmetal Technologies Business Overview & Revenue Model
Company DescriptionLiquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and parts from bulk amorphous alloys to customers in various industries in the United States and internationally. It provides bulk amorphous alloy custom products and parts for applications, which include non-consumer electronic devices, medical products, automotive components, and sports and leisure goods. The company also offers tooling and prototype parts, such as demonstration parts and test samples for customers with products in development; and product licensing and royalty. In addition, it partners with third-party manufacturers and licensees to develop and commercialize liquidmetal alloy products. The company was incorporated in 1987 and is based in Lake Forest, California.
How the Company Makes MoneyLiquidmetal Technologies generates revenue primarily through the licensing of its proprietary amorphous metal alloy technology and the sale of products made from these materials. The company collaborates with various manufacturing partners to produce components and parts that incorporate its unique materials, thereby benefiting from production efficiencies and scalability. Additionally, Liquidmetal Technologies engages in partnerships and joint ventures with companies in different sectors to expand the use of its alloys in new applications, further enhancing its revenue streams. The company's earnings are significantly influenced by its ability to secure licensing agreements, expand its customer base, and innovate within its core technology offerings.
Liquidmetal Technologies Earnings Call Summary
Earnings Call Date:Mar 13, 2025
(Q4-2024)
| % Change Since: |
Next Earnings Date:Mar 12, 2026
Earnings Call Sentiment Positive
The earnings call highlighted significant achievements, including FDA approval for Movano's health rings, expansion in the medical tools industry, and prototype development in the fintech sector. Financially, the company showed revenue growth and progress towards cash flow break-even. However, the impact of tariff increases on Chinese imports poses a challenge.Q4-2024 Updates
Positive Updates
FDA Approval for Movano EV Health Rings
Movano received U.S. FDA 510(k) clearance for the pulse oximeter for its EVMed ring, enabling the pursuit of multibillion-dollar business opportunities in health monitoring solutions.
Expansion in Medical Tools Industry
Completed prototype phase for a startup medical tool company and entered general production. Other medical device prototypes include an annular stapler device, an inhaler device, and cochlear implants.
Prototype Development in Fintech Sector
Prototyping a premium credit card product for a first-tier U.S. financial institution using liquidmetal's unique alloy.
Revenue Growth and Financial Position
Ended 2024 with $900,000 in revenue, an increase from previous years, with $22.5 million in liquid cash and investments, and no debt.
Progress Toward Cash Flow Break-even
Negative $800,000 EBITDA for year-end 2024, which is about half that of year-end 2023, indicating progress towards cash flow break-even.
Negative Updates
Impact of Tariff Increases on Chinese Imports
Tariff increases have led to necessary price hikes for customers, ranging from 10% to 35%, impacting operations.
Company Guidance
During the fiscal year 2024 conference call, Liquidmetal Technologies, Inc. CEO Tony Chung highlighted significant progress and future prospects for the company. Key achievements included the enhancement and increased orders for the Movano EV Health Rings, especially following FDA 510(k) clearance, positioning the product for large-scale health monitoring applications. The company also advanced in the medical tools industry with prototypes for various devices, such as a medical annular stapler and cochlear implants, and secured their first MIM order for surgical applications. Additionally, Liquidmetal is prototyping a premium credit card for a U.S.-based financial institution, leveraging their unique alloy technology. Despite challenges from increased tariffs on Chinese imports, resulting in a 10% to 35% price hike, the company remains optimistic about its financial health. They closed 2024 with $900,000 in revenue, $22.5 million in liquid assets, and zero debt, with a negative EBITDA of $800,000, marking progress toward breakeven. Looking ahead, the company is focused on revenue growth, achieving positive cash flow, and profitability, while actively pursuing a second source manufacturing opportunity in Asia.Liquidmetal Technologies Financial Statement Overview
Summary
Weak operating results dominate: TTM revenue is very small ($0.74M) and down -27.5%, with deeply negative profitability (TTM net margin about -290%) and ongoing losses. The balance sheet is comparatively steadier (debt-to-equity ~0.20 and meaningful equity), but cash flow remains a major concern with continued and worsening cash burn (TTM operating/FCF about -$2.35M).Income Statement
TTM (Trailing-Twelve-Months) revenue is very small ($0.74M) and down materially versus the prior annual period (revenue growth -27.5%). While gross margin is ~30% in TTM (up from ~25% in 2024), the company remains structurally unprofitable with deeply negative operating and net margins (TTM net margin about -290%). Net losses persist across all periods, indicating costs are far out of line with the current revenue base; the main positive is that revenue has shown intermittent growth in some prior years, but the latest trajectory has weakened.12
Very Negative
Balance Sheet
Leverage is moderate with TTM debt-to-equity around 0.20 (improving from ~0.32 in 2024), and equity remains sizable (~$27.7M) relative to total assets (~$29.1M), which provides balance-sheet resilience. However, returns remain negative (TTM return on equity about -7.5%), reflecting continued losses and weak capital efficiency. Overall, the balance sheet looks comparatively stable, but profitability must improve to prevent ongoing erosion of equity over time.56
Neutral
Cash Flow
Cash burn remains a key issue: TTM operating cash flow is -$2.35M and free cash flow is -$2.35M, worse than 2024 (about -$1.16M). While free cash flow showed a positive growth rate in TTM (reflecting a smaller burn versus the prior TTM comparison implied by the dataset), the company is still not generating cash from operations. Free cash flow is roughly in line with net losses (TTM free cash flow to net income ~1.0), suggesting losses are translating into real cash outflow rather than being primarily non-cash.18
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 737.00K | 860.00K | 510.00K | 383.00K | 811.00K | 989.00K |
| Gross Profit | 221.00K | 217.00K | 149.00K | 67.00K | 183.00K | 368.00K |
| EBITDA | -2.59M | -2.99M | -2.73M | -2.71M | -3.69M | -3.14M |
| Net Income | -2.14M | -1.51M | -2.05M | -1.61M | -3.22M | -2.23M |
Balance Sheet | ||||||
| Total Assets | 29.14M | 30.40M | 31.84M | 33.34M | 35.60M | 38.81M |
| Cash, Cash Equivalents and Short-Term Investments | 14.05M | 15.46M | 22.13M | 18.70M | 17.94M | 16.23M |
| Total Debt | 5.56M | 9.45M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.41M | 1.26M | 1.25M | 1.30M | 1.31M | 1.42M |
| Stockholders Equity | 27.73M | 29.22M | 30.67M | 32.12M | 34.37M | 37.47M |
Cash Flow | ||||||
| Free Cash Flow | -2.35M | -1.16M | -1.31M | -1.78M | -2.73M | -2.35M |
| Operating Cash Flow | -2.35M | -1.16M | -1.31M | -1.78M | -2.73M | -2.23M |
| Investing Cash Flow | 5.94M | -1.67M | 7.88M | -258.00K | 5.31M | -15.80M |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 212.00K | 0.00 | 0.00 |
Liquidmetal Technologies Technical Analysis
Positive
0.10
Price Trends
0.11
Positive
0.12
Positive
0.12
Positive
Market Momentum
<0.01
Negative
64.21
Neutral
80.95
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LQMT, the sentiment is Positive. The current price of 0.1 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.11, and below the 200-day MA of 0.12, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.21 is Neutral, neither overbought nor oversold. The STOCH value of 80.95 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LQMT.
Liquidmetal Technologies Risk Analysis
Liquidmetal Technologies disclosed 34 risk factors in its most recent earnings report. Liquidmetal Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Liquidmetal Technologies Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $742.96M | 21.65 | 9.78% | ― | 7.61% | 25.35% | |
72 Outperform | $1.48B | 70.75 | 3.16% | ― | 2.82% | -34.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $426.69M | 36.55 | 5.06% | ― | -12.38% | -0.71% | |
54 Neutral | $320.48M | 27.85 | 1.26% | ― | -3.42% | ― | |
47 Neutral | $116.66M | -55.22 | -7.41% | ― | -27.53% | -64.29% | |
46 Neutral | $185.17M | -34.73 | -8.73% | ― | 0.20% | 88.39% |
* Industrials Sector Average
LQMT
Liquidmetal Technologies
0.13
0.08
212.50%
AP
Ampco-Pittsburgh
9.40
7.31
349.76%
NWPX
Northwest Pipe Company
82.07
39.53
92.92%
PRLB
Proto Labs
62.65
24.36
63.62%
TG
Tredegar
9.55
2.34
32.45%
MEC
Mayville Engineering Company
21.54
7.64
54.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.